advertisement
Frontiers in pharmacology 21
Showing records 1 to 21 | Display all abstracts in Frontiers in pharmacology85115 Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
Sebbag L
Frontiers in pharmacology 2019; 10: 1560
85208 Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms
Su W
Frontiers in pharmacology 2020; 11: 202
84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Reinehr S
Frontiers in pharmacology 2019; 10: 1381
85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Fouda AY
Frontiers in pharmacology 2020; 11: 277
85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Chen W
Frontiers in pharmacology 2020; 11: 302
84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Gomes SC
Frontiers in pharmacology 2019; 10: 1381
85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Eldahshan W
Frontiers in pharmacology 2020; 11: 277
85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Yang X
Frontiers in pharmacology 2020; 11: 302
85115 Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
Moody LM
Frontiers in pharmacology 2019; 10: 1560
85208 Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms
Zhao J
Frontiers in pharmacology 2020; 11: 202
85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Fang J
Frontiers in pharmacology 2020; 11: 302
84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Gassel CJ
Frontiers in pharmacology 2019; 10: 1381
85208 Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms
Fan TJ
Frontiers in pharmacology 2020; 11: 202
85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Narayanan SP
Frontiers in pharmacology 2020; 11: 277
85115 Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
Mochel JP
Frontiers in pharmacology 2019; 10: 1560
85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Caldwell RW
Frontiers in pharmacology 2020; 11: 277
85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Zhang Y
Frontiers in pharmacology 2020; 11: 302
84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Asaad MA
Frontiers in pharmacology 2019; 10: 1381
85228 Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
Zhu W
Frontiers in pharmacology 2020; 11: 302
85227 Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
Caldwell RB
Frontiers in pharmacology 2020; 11: 277
84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Stute G; Schargus M; Dick HB; Joachim SC
Frontiers in pharmacology 2019; 10: 1381
